Search hospitals > North Dakota > Fargo
Sanford Roger Maris Cancer Center
Claim this profileFargo, North Dakota 58102
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
320 reported clinical trials
4 medical researchers
Summary
Sanford Roger Maris Cancer Center is a medical facility located in Fargo, North Dakota. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Sanford Roger Maris Cancer Center is involved with conducting 320 clinical trials across 399 conditions. There are 4 research doctors associated with this hospital, such as Preston D. Steen, Daniel Almquist, Samuel Milanovich, MD, and Maria Bell, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Preston D. SteenSanford Roger Maris Cancer Center4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
113 reported clinical trials
192 drugs studied
Daniel AlmquistSanford USD Medical Center - Sioux Falls4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
77 reported clinical trials
137 drugs studied
Samuel Milanovich, MDSanford Broadway Medical Center4 years of reported clinical research
Expert in Brain Tumor
Expert in Tumors
47 reported clinical trials
101 drugs studied
Maria Bell, MDSanford Cancer Center Oncology Clinic7 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
14 reported clinical trials
32 drugs studied
Clinical Trials running at Sanford Roger Maris Cancer Center
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Gastric Cancer
Bladder Cancer
Colorectal Cancer
Small Cell Lung Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sanford Roger Maris Cancer Center?
Sanford Roger Maris Cancer Center is a medical facility located in Fargo, North Dakota. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Sanford Roger Maris Cancer Center is involved with conducting 320 clinical trials across 399 conditions. There are 4 research doctors associated with this hospital, such as Preston D. Steen, Daniel Almquist, Samuel Milanovich, MD, and Maria Bell, MD.
Where is Sanford Roger Maris Cancer Center located?
The Sanford Roger Maris Cancer Center is located at 820 Fourth St. N, Fargo, ND 58102.
Who should I call to ask about financial aid or insurance network?
**Sanford Roger Maris Cancer Center Financial Assistance:**
- For financial assistance, contact James River Medical Center (JRMC) Cancer Center at (701) 952[...]. They partner with Sanford Health's Roger Maris Cancer Center.
**Insurance Inquiries:**
- For insurance-related questions, reach out to Sanford Health Plan at (800) 752-5863 or memberservices@sanfordhealth.org. Customer service is available from 8 a.m. to 5 p.m. CST.
**Provider Contracting and Fee Negotiation:**
- Providers can contact Sanford Health Plan at (855) 263-3544 for contracting or fee schedule negotiation.
**Prospective Members:**
- Contact Sanford Health Plan's sales team at (888) 535-4831 or sales@sanfordhealth.org for inquiries.
**Medicare Advantage Information:**
- For Medicare Advantage questions, visit the Medicare Advantage Contact Us page.
**Pharmacy Management and Prescription Authorization:**
- Contact Sanford Health Plan at (605) 312-2756 or (855) 305-5062 for pharmacy management and prescription drug coverage prior-authorization.
**Utilization Management:**
- For prior-authorization of medical services and utilization review, contact Sanford Health Plan at (605) 328-6807 or (800) 805-7938.
**Care Management Programs:**
- For case management, health management, and social work programs, contact Sanford Health Plan at (888) 315-0884.
**Agents:**
- Agents can reach Sanford Health Plan's sales team at (888) 535-4831 or sales@sanfordhealth.org.
**Compliance and Reporting:**
- To report potential fraud, waste, and abuse, call the Compliance Hotline at (877)-473-0911 (TTY:711).
**NDPERS Health Insurance Partnership:**
- For NDPERS partnership inquiries, contact (701) 751-4125 or (800) 499-3416.
**Media Relations:**
- Contact Sanford Health Media Relations at (605) 366-2432.
**24/7 Health Concerns:**
- For health concerns, contact My Sanford Nurse at (800) 952-2523, available 24/7.
What insurance does Sanford Roger Maris Cancer Center accept?
The Sanford Roger Maris Cancer Center accepts various insurance plans, including those provided by Sanford Health Plan. For detailed information on accepted insurance plans, please contact the hospital directly or visit their official website.
What awards or recognition has Sanford Roger Maris Cancer Center received?
The Sanford Roger Maris Cancer Center, located in Fargo, North Dakota, is celebrated for its excellence in diversity, equity, and inclusion initiatives by the American Medical Association. It is also recognized as a National Pancreas Foundation Center of Excellence, underscoring its dedication to delivering superior pancreatic cancer care.